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Induction of IFNα or IL-12 depends on
differentiation of THP-1 cells in dengue infections
without and with antibody enhancement
Rong-Fu Chen1, Lin Wang2, Jiin-Tsuey Cheng3 and Kuender D Yang1*
Abstract
Background: Appropriate induction of the early Th1 cytokine IL-12 is a critical defense directed against viral
infection. We have previously shown that different viruses elicited either IL-12 or IFNα dependent Th1 reactions.
Using dengue-2 virus, we sought to explore how dengue-2 induced IL-12 or IFNα expression by monocytic and its
derived dendritic cells.
Methods: We employed human monocytic cell line, THP-1, to investigate whether differentiation of monocytic cells
is involved in the switch between IFNα and IL-12 induction. Flow cytometry, RT-PCR and ELISA were respectively
used to determine cell differentiation, IL-12 and IFNα mRNA expression and protein production.
Results: THP-1, expressing CD123, which is a plasmacytoid dendritic cell marker, but not CD14, CD11b or CD11c
revealed IFNα mRNA expression while stimulated by dengue-2. In contrast, PMA-induced THP-1 differentiation
toward monocytic cells expressed CD11b+, and CD14+, but not CD123, and revealed exclusively IL-12 expression
while stimulated by dengue-2. Further studies showed that CD123+ expressing THP-1 cells elicited higher IFNα
expression in dose and time dependent induction after infection, and PMA-induced monocytic differentiation of
THP-1 cells revealed IL-12 expression. Antibody-dependent enhancement of DEN-2 infection significantly
suppressed the DEN-2 induced IL-12 p40 expression in monocytic differentiated THP-1 cells.
Conclusions: Clarification and modulation of the early Th1 reaction in different monocytic cells may change or
prevent complication from dengue infection.
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Background
Dengue fever (DF) is transmitted by mosquitoe bite
which introduces dengue viruses (DEN) including 4 ser-
otypes. DF is highly prevalent in tropical and subtropical
areas, with at least 50 million new cases each year [1,2].
Occasional, DF progresses to dengue hemorrhagic
fever (DHF), a potentially life threatening complica-
tion associated with vascular leakage, hemorrhage,
thrombocytopenia and shock [3-5]. More than 1 billion
people are at risk of dengue infection and there are ap-
proximately 100 million cases of DF and 500,000 cases
of DHF every year [6]. DHF has been classified into four
grades on the basis of clinical presentation. The mildest
is grade I and the most severe is grade IV [7,8]. The first
indication of an immunological mechanism for DHF was
the observation in a Bangkok outbreak of DHF in 1960s
[9]. In that outbreak, over 85% of children with DHF
had high DEN heterotypic cross-reactive antibody titers,
suggesting an antibody-dependent enhancement (ADE)
of DEN infection in the pathogenesis [10]. Monocytes,
macrophages and dendritic cells (DCs) play a crucial role
in immune responses against virus infection, in which
IL-12 and IFN α/β are early mediators of Th1 cell im-
munity [11-13]. It is well known that IL-12 derived from
monocytes or dendritic cells can polarize Th1 reaction
[14-16]. Whether type I interferons are involved in IFNγ
induction mediating Th1 reaction remains controversial
[17,18]. Recently, we have found that different microorganisms
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could induce IL-12 or IFNα to polarize Th1 reaction in a
mutually exclusive fashion [16]. Different viruses induce
IL-12 or IFNα mutually exclusive is usually mediated via
ligation of different toll-like receptors (TLRs) [19-21].
DCs play a central role in the initiation of T cell-
mediated antiviral immune responses [22,23]. Different
DCs release different cytokines to polarize T helper (Th)
cells. Plasmacytoid DCs release IFN α/β to polarize Th1
reaction [24], myeloid DCs release mainly IL-12 to en-
hance Th1 reaction [25], and regulatory DCs release IL-
10 or TGFβ to polarize Treg [26]. Besides, DCs are very
effective at taking up antigen, by pinocytosis of soluble
compounds, macropinocytosis of high-molecular-weight
antigens and phagocytosis of particles [27]. After
encountering antigen, DCs migrate to the lymph
nodes where DCs activate specific T cells [28]. The
migration is dependent on the expression of chemo-
kine receptors, which enable the cells to sense chemo-
tactic gradients, and cell adhesion molecules for
interaction with endothelial cells. Several of these
molecules play important regulatory roles, such as
ALCAM, which is expressed on activated T cells and
on monocyte-derived DCs, and might play a role in
DC migration [29].
We have previously shown that DHF, a potential fatal
complication of DF, is associated with higher Th2 reac-
tion [30-32] and lower Th1 polarization [33]. Moreover,
we have also demonstrated that varicella-zoster virus
and Bacillus Calmette-Guerin (BCG) induce IFNα and
IL-12 production, respectively [16]. This study was
conducted to investigate whether differentiation of
monocytic cells is involved in the switch between IFNα
and IL-12 induction after dengue infection, and whether
ADE of dengue infection could modulate the production
of IFNα and IL-12 by different monocytic cells.
Monocytes and macrophages are recruited to sites of
inflammation and play critical roles in innate host
defense mechanisms. THP-1, human promonocytic
leukemia cells, grow as nonadherent promonocytes, and
differentiate to macrophage-like cells upon treatment
with PMA [34,35]. PMA, a potent activator of PKC,
arrests THP-1 proliferation and induces the expression
of several macrophage characteristics [36-38]. It remains
unclear whether THP-1 monocytic cells can express
IFNα or IL-12, depending on differentiation; or THP-1
monocytic can develop into different DCs, responsible
for exclusive IFNα or IL-12 expression. ADE of dengue
has long been implicated in severe, usually secondary,
DEN infections. Preexisting heterotypic antibodies of
dengue might promote dengue infection via their Fc-
gamma receptor (FcγR) [39], this may not only facilitate
the virus’ entry, but also modifies innate and adaptive
immune responses [40]. Employing DEN-2 virus, which
is known to cause the most outbreaks of DHF, associated
with altered Th1/Th2 reaction [41-45], we attempted to




Phorbol 12-myristate 13-acetate (PMA), and dimethyl
sulfoxide (DMSO) were purchased from Sigma Chemical
Co. (St. Louis, MO). RPMI 1640 culture medium was
obtained from Gibco BRL (Grand Island, NY, USA).
Fetal bovine serum (FBS), gentamicin, and L-glutamine
were purchased from Gibco BRL, Inc. (Grand Island,
N.Y., USA).
Cells culture
Monocytic THP-1 cells were grown in RPMI 1640, 10%
FBS (endotoxin level <0.25 EU/mL; Gibco BRL, Grand
Island, N.Y., USA), 2 mM L-glutamine (Gibco BRL,
Grand Island, N.Y., USA) at 37°C, and 5% CO2 incuba-
tor. THP-1 cells (2×105 cells/ml) were subcultured every
3 days, and PMA (8 nM) was used to induce THP-1 cell
differentiation. To study time dependent effect, cells
(2×106 cells/ml) were used for studies with dengue-2 in-
fection at multiplicity of infection (MOI) = 1.0 for 6 to
72 hours as indicated. For studying different infection
dose, we used MOI from 0.1, 0.5, 1, 5 and 10 to study its
dose-dependent effect.
Dengue-2 virus preparation
Dengue virus type 2 (DEN-2, New Guinea C strain,
ATCC) was obtained from the Institute of Preventive
Medicine, National Defense Medical Center, Taipei.
Viruses were propagated in C6/36 mosquito cells in
Eagle's minimal essential medium (MEM) (Gibco BRL,
Grand Island, N.Y., USA) containing nonessential amino
acids (Gibco BRL, Grand Island, N.Y., USA), 1% sodium
pyruvate, 0.2% sodium bicarbonate and supplemented
with 1% antibiotic (Gibco BRL, Grand Island, N.Y.,
USA) and 10% heat-inactivated FBS at 28°C for 5 days.
Baby hamster kidney cells (BHK-21) were grown in
MEM as described above. A large collection of virus cul-
ture was pooled and showed a titer of 1.0 × 107 PFU/ml
determined by real-time quantitative RT-PCR as previ-
ously described [30]. All experiments about DEN infec-
tion were set at MOI = 1.
Flow cytometric analyses of cell surface markers
In order to characterize the change of cell differentiation
markers on THP-1 cells, we measured pDC-specific and
mDC-specific markers on THP-1 cells by flow cytome-
try. These cells (2 × 106 cells/ml) are treated with and
without 8 nM PMA for 72 hours. Cell surface stainings
were performed by direct immunofluorescent assay with
fluorescence-conjugated mAbs (CD14-PE, CD11b-PE,
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CD11c-PE, and CD123-FITC) and corresponding isotype
control antibodies for 30 minutes. After washing in PBS
twice, cells were fixed in 2% paraformaldehyde for
20 min, washed, and resuspended at ~106 cells per milliliter
before acquisition.
Real-time quantitative RT-PCR analysis of IL12B and IFNα
mRNA expression
We subjected total RNA extracted from THP-1 cells
with and without differentiation treatment to quantita-
tive analysis of mRNA expression of IL12B and IFNα. In
brief, the cell pellet was mixed with 0.5 ml of Tri-Zol so-
lution (Invitrogen, California, USA). After thorough
vortexing, samples were added 0.1 ml of chloroform
(Scharlau, sa, Barcelona, European Union) for phase
separation. After centrifugation, the upper aqueous
phase was transferred to a fresh DEPC-treated eppen-
dorf and the same volume of isopropanol (Merck KGaA,
Darmstadt, Germany) was added for RNA precipitation
at −20°C for 1 hour. The RNA was harvested by centri-
fugation at 12,000 × g for 10 minutes at 4°C, followed by
75% ethanol (Merck KGaA, Darmstadt, Germany) pre-
cipitation. Finally, the RNA was subjected to the real-
time RT-PCR detection with SYBR Green PCR reagents
(RealQ-PCR Master Mix Kit, Ampliqon) using the ABI
PRISM 7500 instrument (Applied Biosystems, Foster
City, CA) as previously described [46]. Primers for the
quantitative detection of target mRNAs were designed
by using Primer Express computer software (Applied
Biosystem, Foster City, CA). For the IL12B gene, the pri-
mer sequences were 5’- acctccacctgccgagaat-3’ (forward)
and 5’- acctccacctgccgagaat-3’ (reverse). For the IFNα.
gene, the primer sequences were 5’-atttctgctctgacaacctc-
3’ (forward) and 5’-tgacagagactcccctgatg-3’ (reverse) [47].
In order to evaluate PCR efficiency, a 3 replicates and 5-
log dilution series were performed. A slope of −3.3 ±10%
reflects an efficiency of 100% ±10%. Samples were ana-
lyzed in three independent duplicate experiments. The
RT-PCR cycling parameters were set as follows: the RT
reaction at 50°C, 2 minutes; 60°C, 30 minutes; and 95°C,
5 minutes; followed by 40 cycles of PCR reactions at 94°C,
20 seconds, and 60°C, 1 minute. The results were
detected in a real-time fashion and recorded on a plot
showing fluorescence vs. time. RT-PCR products were
also visualized on ethidium bromide-stained 1.5% agar-
ose (Pierce Co., Rockford, IL, USA) gel with a 100-bp
ladder (Pharmacia Biotech, Piscataway, NJ, USA) as a
reference. The increase of the IL12B and IFNα mRNA
expression were therefore calculated assuming 100%
efficient PCR where each Ct was normalized to
β-actin mRNA expression as shown by the equation at
2 [Ct1(target) −Ct1(actin)][Ct2(target) −Ct2(actin)]. The Ct1 (target)
and Ct2 (target) represent the Ct values for the IL12B or
IFNα gene expression in treated and mock samples,
respectively. Ct1 (actin) and Ct2 (actin) represent the Ct
values for the β-actin gene.
Measurement of IFNa, and IL-12 p40 levels
To measure IL-12 protein production, 106 THP-1 cells
with or without PMA treatment per well are seeded into
1-ml culture medium in triplicates in 24-well tissue-culture
plates and incubated at 37°C in humidified 5% CO2 at-
mosphere in the presence or absence of different stimuli,
as indicated above. After 24 and 72 hours, cell-free cul-
ture supernatants are removed and assayed for multi-
species IFN-α (PBL Biomedical Laboratories, Endogene
Inc., Cambridge, MA, USA), IL-12 p40 (R&D Systems,
Minneapolis, MN, USA) concentrations using ELISA.
The results were calculated from interpolation in a
standard curve made from a series of well-known con-
centrations of commercial standards [30,32].
Assessment of antibody-dependent enhancement of virus
infections in differentiated THP-1 cells
To assess ADE, DEN-2 viruses were preopsonized with
and without DEN-1 or DEN-2 immune sera at 4°C for
60 min as previously described [32], PMA-differentiated
THP-1 cells (2 x 105cells/ml) were incubated with DEN-
2 virus with and without DEN immune sera at MOI of 1
at 37°C for 60 min. The infected cells were washed to re-
move extracellular viruses before culture in RPMI 1640.
The infected PMA-differentiated THP-1 cells were cul-
tured for 24 hours before the culture supernatants were
harvested for determination of DEN-2 virus titers by
real-time RT-PCR assay for 40 cycles using TaqMan
technology (Applied Biosystems, Foster City, CA). The
forward primer, reverse primer and nested fluorescent
probe sequence for detecting DEN-2 were 5'-GGC TTA
GCG CTC ACA TCC A-3', 5'-GCT GGC CAC CCT
CTC TTC TT-3', and FAM-CGC CCA CCA CTA TAG
CTG CCG GA-TAMRA, respectively [30]. The intracel-
lular viruses were harvested from the cell pellets after
washing twice with PBS to remove extracellular virus.
The cell pellets were frozen and thawed for three times
to release intracellular DEN-2 virus, then resuspended
to 20 μl and subjected to real-time RT-PCR assay.
Data and statistical analyses
Data are presented as mean ± SEM values. Mann
Whiteney U test was used to analyze IL12B and IFNα
RNA expression levels between undifferentiated and
differentiated THP-1 cells with and without DEN-2 in-
fection. A P value of < 0.05 was considered statistically
significant. All analyses were performed using SPSS
13.0 (SPSS Inc. Chicago, IL, USA).
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Results
Undifferentiated THP-1 expressing pDC markers released
IFNα but not IL-12 after DEN-2 infection
In order to characterize the expression of cell markers
on THP-1 cells, we assessed the CD123 levels, a pDC-
specific marker, on THP-1 cells by flow cytometry. As
shown in Figure 1A, CD123 was expressed on the sur-
face of THP-1 and down-regulated on the PMA-
differentiated THP-1 cells. To investigate whether
THP-1 cells elicited Th1 promoting cytokines under
DEN-2 infection, cellular RNA was extracted and
assessed using real-time RT-PCR after 24 h infection.
Higher levels of IFNα mRNA but not IL12B mRNA
were induced in post-infected THP-1 cells by DEN-2
(Figure 1B).
Differentiated THP-1 expressing mDC markers released IL-
12 but not IFNα after DEN-2 infection
THP-1 cells grew as a single-cell suspension, and only a
few cells spread onto the flask substrate. Approximately
80% of the cells attached to the substrate as early as 3 h
after the addition of PMA (8 nM). After a 72-h treat-
ment with PMA, THP-1 spread onto the substrate to be
irregular and flattened in shape. Addition of DMSO only
at the same dilutions required for obtaining the given
concentrations of PMA in culture system did not induce
adherence of the cells to the substrate.
The effect of PMA treatment on the expression of sur-
face markers of THP-1 cells was examined by flow cyto-
metry. THP-1 treated with 8 nM PMA expressed more
mDC cell markers such as CD14, CD11b, and CD11c
(Figure 2A-C), but not CD123, pDC cell markers
(Figure 1A). To analyze whether PMA-treated THP-1
cells elicited Th1 promoting cytokines under DEN-2 in-
fection, cellular RNA was extracted and assessed using
real-time RT-PCR after 24 h DEN-2 infection. Higher
levels of IL12B mRNA but not IFNα mRNA were
induced in PMA-treated THP-1 cells after 24 h DEN-2
infection (Figure 2D).
Dose dependent and kinetic induction of IFNα /IL12B
mRNA in THP-1 cells with or without PMA differentiation
after DEN-2 infection
Undifferentiated THP-1 cells elicited higher produc-
tion of IFNα mRNA (Figure 1B); PMA-treated THP-1
cells after DEN-2 infection expressed IL12B mRNA
(Figure 2D). To investigate whether Th1 promoting
cytokines induced in undifferentiated THP-1 cells were
dose dependent, cells were infected by different DEN-2
titers (MOI = 0.1 ~ 5) and RNA were assessed by real-
time RT-PCR. As shown in Figure 3A, THP-1 elicited
IFNα mRNA levels when cells infected by DEN-2 even
at lower MOI, and induced IFNα mRNA reached the
maximum at MOI = 5. To analyze whether Th1 promot-
ing cytokines were kinetically induced in THP-1, cells
were infected by DEN-2 at MOI = 1 at different time
from 30 min, 1 h, 2 h, 6 h, and 24 h. Results showed that
the IFNα mRNA expressing levels were kinetically
increased in undifferentiated THP-1 cells and reached
the maximum at 24 h post-infection of DEN-2
(Figure 3B). Interestingly, the IL12B mRNA expressing
levels were also kinetically induced and dose-dependent
in PMA-differentiated THP-1 cells and reached its max-
imum induction at 24 h post-infection of DEN-2
(Figure 3C, D). In order to understand whether the in-
duction of Th1 promoting cytokines were limited to
transcriptional level, we assessed the cytokine levels by
ELISA in the same reactions. However, we could not de-
tect the IFNα production in the supernatants of DEN-2







































Figure 1 Flow cytometric analysis of CD123 expression in THP-
1 with or without PMA differentiation (A). Expression of IFNA and
IL12B mRNA expression in THP-1 cells with DEN-2 infection (B). Six
RNA samples from cells were subjected to testing IFNA (■) and
IL12B (□) mRNAs by SYBR Green real-time RT-PCR analysis.
(p = 0.019).
Chen et al. BMC Infectious Diseases 2012, 12:340 Page 4 of 9
http://www.biomedcentral.com/1471-2334/12/340
IL-12 p40 proteins were kinetically and dose-dependently
detected in PMA differentiated THP-1 cells Results
showed that IL-12 p40 production could be induced at
1 h post-infection of DEN-2 and also reached its max-
imum at 24 h post-infection of DEN-2 in differentiated
THP-1 cells, but not in undifferentiated THP-1 cells
(Figure 3E, F).
Down-regulation of IL12B in antibody dependent
enhancement of DEN-2 infected differentiated THP-1 cells
Antibody-dependent enhancement of DEN-2 infection
occurred when sub-neutralizing antibodies facilitated
DEN-2 infection via Fc receptors (FcR). To investigate
the role of IL-12 p40 in ADE of DEN-2 infection, we
compared the viral replication and IL12B expression in
the differentiated THP-1 cell using real-time RT-PCR.
As shown in Figure 4A, we found that the sub-
neutralizing DEN-1 antiserum could enhance DEN-2
replication in differentiated THP-1 cells from 2.64×105
copies/ml to 1.49×106 copies/ml in the presence of anti-
serum at 1:1250 dilution. However, anti-DEN2 antiserum
at 1:1250 dilution did not enhance DEN-2 replication
in differentiated THP-1 cells (2.64×105 copies/ml vs.
3.28×105 copies/ml). To measure the expression of IL-
12 p40 levels in the ADE of DEN-2 infection of differen-
tiated THP-1 cells, we found that DEN-2 infection
induced a higher IL12B expression (Figure 4B). Presence
of anti-DEN1 antiserum at 1:1250 dilution, but not anti-
DEN2 antiserum, significantly suppressed the DEN-2
induced IL12B expression in differentiated THP-1 cells.
Discussion
Several prospective studies have concluded that DHF is
more common in secondary DEN infections than in pri-
mary DEN infections [9,48]. Despite extensive studies,
the pathogenesis of DHF cannot be fully attributed to
the ADE. Activation of dengue virus-specific T cells and
dengue virus-infected monocytes may result in increased
capillary permeability in patients with DHF [49,50]. Re-
cently, cytokines related to dominant Th2 reaction have
been related to the pathogenesis of DHF [44,48,51,52].
We showed that increase of Th1 cytokine, IL12B
expression in differentiated THP-1 cells was found in














































Figure 2 Flow cytometric analysis of CD14, CD11b, CD11c expression in THP-1 with or without PMA differentiation (A-C). Expression of
IFNA and IL12B mRNA expression in PMA-treated THP-1 cells with DEN-2 infection (D). Six RNA samples from cells were subjected to testing IFNA
(■) and IL12B (□) mRNAs by SYBR Green real-time RT-PCR analysis. (p = 0.016).
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heterotypic antibody mediated DEN-2 infection signifi-
cantly enhanced DEN-2 replication, but suppressed the
IL12B expression.
Distinct DC subsets are known to exhibit intrinsic dif-
ferences in their ability to: 1) regulate the quality of the
Th response (Th1, Th2, or cytotoxic T lymphocyte
[CTL]); 2) produce antiviral type I IFNs; and 3) cross-
present exogenous Ags to CD8+ T cells [53]. Our results
indicate that treatment of human monocytic leukemia
cell line, THP-1, cells with 8 nM PMA for 72 h
promotes a differentiation phenotype that is character-
ized by morphological changes and altered IFNα gene
induction. The PMA could induce THP-1 cells to differ-
entiate toward macrophage has been well demonstrated
[54-56]. We however demonstrated an up-regulation in
expression of mDC-related molecules associated with
monocyte differentiation, notably CD11b, CD11c and
CD14. Concomitantly, the expression of CD123 was se-
lectively downregulated in the PMA differentiated THP-
1 cells. Theses cell surface markers were partly similar to
(A) Without PMA (B) Without PMA 
(C) With PMA (D) With PMA
(E)  With PMA (F) With PMA
M.O.I.


















































































































































































Figure 3 Dose-dependent and kinetic induction of IFNA and IL12B expression in DEN-2-infected THP-1 cells with or without PMA
differentiation. A series of M.O.I. of DEN-2 were assessed at post-infection 24 h, RNA samples from THP-1 (A) or PMA-differentiated THP-1 (C)
cells were subjected to testing IFNA and IL12B mRNAs by SYBR Green real-time RT-PCR analysis. A different post-infection time of DEN-2 were
assessed at M.O.I.=1, RNA samples from THP-1 (B) or PMA-differentiated THP-1 (D) cells were subjected to testing IFNA and IL12B mRNAs by SYBR
Green real-time RT-PCR analysis. The similar dose response (E) and kinetic induction (F) of IL-12 p40 proteins in the supernatants of DEN-2
infected PMA-differentiated THP-1 cells by ELISA in the same reactions.
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the criteria of differences between myloid DCs and plas-
macytoid DCs. THP-1 cells induced elevated IFNα
mRNA expression under DEN-2 infection, however,
PMA-differentiated THP-1 cells elicited higher IL12B
mRNA expression and protein levels under the same
infection. The induction of early Th1 cytokines was
dose-dependent and time-dependent in THP-1 with or
without PMA differentiated cells.
Conclusion
Human blood DCs can be divided into several distinct
phenotypic and functional subpopulations, and both
monocytes-derived DCs and PMA-differentiated THP-1
cells are of the myeloid CD11b+ CD11c+ and CD14+, re-
sembling their in vivo myeloid counterpart [29]. We
showed that THP-1, likes pDCs, responded to DEN-2 by
secreting IFNα; on the other hand, PMA-differentiated
THP-1 cells, act as mDC, responded to DEN-2 by se-
creting IL-12. This model may be a good model system
for studying early innate immunity of virus infections,
and provide a better strategy to prevent infection and
complication.
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